Susquehanna International Group, LLP Idera Pharmaceuticals, Inc. Call Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	SELL	$0.38 - $0.53 $10,374 - $14,469	-27,300 Reduced 50.0%	27,300 $10,000
Q2 2022 Aug 15, 2022	BUY	$0.32 - $0.74 $2,912 - $6,734	9,100 Added 20.0%	54,600 $25,000
Q1 2022 May 16, 2022	BUY	$0.41 - $0.7 $5,658 - $9,660	13,800 Added 43.53%	45,500 $23,000
Q4 2021 Feb 14, 2022	SELL	$0.53 - $1.03 $35,616 - $69,216	-67,200 Reduced 67.95%	31,700 $18,000
Q3 2021 Nov 15, 2021	BUY	$1.0 - $1.18 $10,000 - $11,800	10,000 Added 11.25%	98,900 $102,000

Q2 2021 Aug 11, 2021	BUY	$1.01 - $1.58 $12,322 - $19,276	12,200 Added 15.91%	88,900 $107,000
Q1 2021 May 17, 2021	BUY	$1.23 - $5.98 $79,827 - $388,102	64,900 Added 550.0%	76,700 $100,000
Q4 2020 Feb 16, 2021	BUY	$2.09 - $5.18 $24,662 - $61,124	11,800 New	11,800 $43,000

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.